(NPR) New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial

New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial








A view of Moderna headquarters in Cambridge, Mass., earlier this month. Moderna is touting preliminary data from a limited coronavirus vaccine trial.



Maddie Meyer/Getty Images


hide caption





toggle caption




Maddie Meyer/Getty Images











New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial






Cambridge, Mass.-based Moderna, Inc. is reporting preliminary data suggesting its COVID-19 vaccine is safe and appears to be triggering an immune response in test subjects.








Loading...